NCT05749575 2023-03-01
Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
5 trialsNCT05491694 2022-08-08
HIFU
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05291910 2022-03-23
Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer
ChineseAMS
Phase 4 Unknown
NCT04389073 2022-02-25
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04234620 2020-01-21
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Shanghai Junshi Bioscience Co., Ltd.
Unknown